Baxdrostat reduces blood pressure in previously treatment-resistant hypertension
1. Compared to placebo, baxdrostat showed a dose-dependent reduction in blood pressure in patients...
Read MoreFeb 9, 2023
1. Compared to placebo, baxdrostat showed a dose-dependent reduction in blood pressure in patients...
Read MoreFeb 9, 2023
1. In a retrospective cohort study, the use of alpha-2-adrenergic agonists to treat...
Read MoreFeb 9, 2023
1. In this randomized controlled trial, machine perfusion of the kidney reduced delayed graft...
Read MoreFeb 9, 2023
1. After a 24-week treatment period, a significantly greater proportion of patients randomized to...
Read MoreFeb 7, 2023
1. For patients with idiopathic pulmonary fibrosis (IPF), there was no difference in pulmonary...
Read MoreFeb 7, 2023
1. In this retrospective cohort study, there was an increased prevalence of age-, race-, and body...
Read MoreFeb 7, 2023
1. Experiencing either physical abuse alone or both physical and sexual abuse before the age of 18...
Read MoreFeb 6, 2023
1. Quality of life at one year was improved in patients with heart failure with preserved ejection...
Read MoreFeb 6, 2023
1. In this network meta-analysis, there was no difference between exercise, oral non-steroidal...
Read MoreFeb 6, 2023
1. In a large population-based cohort, age-related macular degeneration (AMD) diagnosis was...
Read MoreFeb 6, 2023
1. Supplemental Nutrition Assistance Program (SNAP) participation is associated with decreased...
Read MoreFeb 3, 2023
1. In this cross-sectional study, serum cystatin C levels were similar in both Black and White...
Read MoreFeb 3, 2023
1. In this randomized control trial of knee osteoarthritis patients, there was no significant...
Read MoreFeb 2, 2023
1. In the EXPLORER-HCM trial, among 251 included patients, there were significant improvements...
Read MoreFeb 2, 2023
1. Efanesoctocog alfa was superior to prestudy factor VIII prophylaxis in preventing bleeding in...
Read MoreFeb 2, 2023
1. In this retrospective cohort study, the incidence of hydroxychloroquine retinopathy was 2.5% at...
Read MoreFeb 2, 2023
1. Patients who received adjuvant S-1 had prolonged overall survival and relapse-free survival...
Read MoreJan 31, 2023
1. At week 16, all rocatinlimab groups reported significant improvements in eczema severity. 2....
Read MoreJan 31, 2023
1. Epstein-Barr viral load monitoring was associated with reduced post-liver transplant...
Read MoreJan 31, 2023
1. Bisphosphonates, denosumab, abaloparatide, teriparatide, and romosozumab use are associated...
Read More